Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
OmniAb (OABI.US) is up more than 36% in pre-market trading after the company announced a $370 million drug development agreement with Eli Lilly.

OmniAb (OABI.US) is up more than 36% in pre-market trading after the company announced a $370 million drug development agreement with Eli Lilly.

智通财经智通财经2026/08/17 10:46
Show original
OmniAb (OABI.US) surged more than 36% in pre-market trading after the company announced a $370 million drug development agreement with Eli Lilly.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!